Standout Papers
Immediate Impact
2 by Nobel laureates 8 from Science/Nature 61 standout
Citing Papers
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Works of Anderley Gordon being referenced
Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study
2005
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.
1997 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anderley Gordon | 569 | 896 | 526 | 31 | 1.3k | |
| W ten Bokkel Huinink | 411 | 543 | 448 | 22 | 1.2k | |
| Eizo Kimura | 381 | 735 | 363 | 20 | 1.1k | |
| M E van der Burg | 454 | 669 | 637 | 18 | 1.4k | |
| Ahmed Elattar | 391 | 689 | 448 | 32 | 1.1k | |
| Barbara Kulp | 522 | 730 | 574 | 37 | 1.6k | |
| Antonio Santillan | 655 | 858 | 286 | 27 | 1.5k | |
| Henric Malmström | 700 | 1193 | 467 | 29 | 1.7k | |
| Abbie L. Fields | 321 | 451 | 312 | 42 | 1.2k | |
| C. Mangioni | 499 | 872 | 402 | 50 | 1.5k | |
| I. Vergote | 631 | 1029 | 365 | 67 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...